Skip to main content

Perinatal Substance Use Webinar Series

Sessions held every other month (odd numbered months) from 12:00 – 1:00 p.m. (Central Time)

2024 Session Dates (more dates will be released throughout the year)

° January 24
° March 12
° May 22

This series was designed to meet the needs of a broad range of perinatal stakeholders who work with people affected by perinatal substance use. Specific topics are drawn from suggestions submitted to WAPC and from current trends in perinatal health. If you have suggestions for presentations, please use this form. 

The interactive live sessions will be held via Zoom; recordings will be available. Continuing education for attending both live or recorded sessions will be available for both CNE and CME. These presentations are intended for perinatal care stakeholders. The presenters have no relevant financial relationships with ineligible companies.

2024 Session Schedule

All sessions are held live on the dates below from 12:00 – 1:00 p.m. CT via Zoom. More topics and session dates will be released throughout 2024.  

January 24 – Reporting Guidelines and Practices

Presented by Allison Whitaker, BA

This presentation will describe the results of a study evaluating provider understanding and of Wisconsin laws regarding reporting substance use and pregnancy. 

March 12 – Stigma and Bias from the Peer Perspective

Presented by Tanya Kraege, APSW, CSAC, MSW, CCAR Coach, CCAR Trainer, WI CPS Trainer

Stigma and bias have a negative effect on care for pregnant persons with substance use disorder. The presenter will discuss the impact of stigma and bias from the peer’s perspective. 

May 22 – Infant and Child Outcomes after In Utero Exposure to drugs

Presented by Elizabeth Goetz, MD, MPH

There are good reasons to be concerned about the impact prenatal exposure to substances can have on the developing infant and child. This presentation will review the latest information on the impact of in utero exposure on longer-term infant and child outcomes. 


There is no cost to attend the webinars. 

Continuing Education

Learners will have three weeks following each session to complete the evaluation. Those that meet that deadline will receive their CE certificate within 1 month of the session date.  

To receive credit, participants must attend the entire session and complete the evaluation.

Nursing Continuing Professional Development 

The Wisconsin Association for Perinatal Care (WAPC) is an approved provider of nursing continuing professional development by the Wisconsin Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.  

This internet live course meets the criteria for a maximum of 1.0 contact hours. 

Continuing Medical Education 

The Wisconsin Association for Perinatal Care is accredited by the Wisconsin Medical Society to provide continuing medical education for physicians.  

The Wisconsin Association for Perinatal Care (WAPC) designates this internet live course for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Certificate of Participation 

Participants can also request a certificate of participation not associated with an accrediting body. To receive the certificate, participants must complete the evaluation and request the certificate. 

Planning Committee

Eva Fassbinder Brummel, MPH

Ayanda Crispin, BA

Erin Cronn, BSN, RN

Jessica Ewing, CNM

Charlene Galston, RNC-OB, BSN, ME-PD, IBCLC

Kate Gillespie, DNP, RN, CPH

Maria Green, MSN, RNC-OB, C-EFM, C-ONQS

Megan Hardy, BSN, RN

Teresa Lass, BSN, RNC-MNN

Janet Letter, MSN, RNC-OB, C-EFM

Nichole Logan, BSN, RN

Marissa Meagher, MPH

Laura Megna, MSN, IBCLC, RNC-NIC

Kyleigh Menke, RN, BSN

Kyle Mounts, MPH

Sara Onitsuka

Courtney Pickar, MS, RNC-OB, ACNS-BC, C-ONQS, C-EFM

Jeanne Rosendale, MSN, BSN, RN

Charles Schauberger, MD

Eileen Zeiger, MA

No one in control of content has any relevant financial relationships with ineligible companies.*

*Ineligible companies are those whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients.